[HTML][HTML] Review of current COVID-19 diagnostics and opportunities for further development

Y Mardian, H Kosasih, M Karyana, A Neal… - Frontiers in …, 2021 - frontiersin.org
Diagnostic testing plays a critical role in addressing the coronavirus disease 2019 (COVID-
19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV …

[HTML][HTML] Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights

S Ali, M Alam, F Khatoon, U Fatima, AM Elasbali… - Biomedicine & …, 2022 - Elsevier
The unexpected emergence of the new Coronavirus disease (COVID-19) has affected more
than three hundred million individuals and resulted in more than five million deaths …

[HTML][HTML] Deep learning-based meta-classifier approach for COVID-19 classification using CT scan and chest X-ray images

V Ravi, H Narasimhan, C Chakraborty, TD Pham - Multimedia systems, 2022 - Springer
Literature survey shows that convolutional neural network (CNN)-based pretrained models
have been largely used for CoronaVirus Disease 2019 (COVID-19) classification using …

Potential drug targets of SARS-CoV-2: From genomics to therapeutics

A Shamsi, T Mohammad, S Anwar, S Amani… - International Journal of …, 2021 - Elsevier
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from
China has become a global threat due to the continuous rise in cases of Coronavirus …

[HTML][HTML] Genomic variations in the structural proteins of SARS-CoV-2 and their deleterious impact on pathogenesis: a comparative genomics approach

T Mohammad, A Choudhury, I Habib… - Frontiers in cellular …, 2021 - frontiersin.org
A continual rise in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection
causing coronavirus disease (COVID-19) has become a global threat. The main problem …

Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 …

K Jung, S Shin, M Nam, YJ Hong… - Journal of clinical …, 2021 - Wiley Online Library
Background SARS‐CoV‐2 pandemic is currently ongoing, meanwhile vaccinations are
rapidly underway in some countries. The quantitative immunoassays detecting antibodies …

[HTML][HTML] Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir

PA Negru, AF Radu, CM Vesa, T Behl… - Biomedicine & …, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) represents an unmet clinical need, due to a
high mortality rate, rapid mutation rate in the virus, increased chances of reinfection, lack of …

[HTML][HTML] Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives

T Dong, M Wang, J Liu, P Ma, S Pang, W Liu… - Chemical Science, 2023 - pubs.rsc.org
The disastrous spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has induced severe public healthcare issues and weakened the global economy …

[HTML][HTML] Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro

DSM Lewis, J Ho, S Wills, A Kawall, A Sharma… - Scientific reports, 2022 - nature.com
The most common host entry point of human adapted coronaviruses (CoV) including SARS-
CoV-2 is through the initial colonization in the nostril and mouth region which is responsible …

[HTML][HTML] Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations

DS Jairajpuri, A Hussain, K Nasreen… - Saudi Journal of …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has emerged from China and globally
affected the entire population through the human-to-human transmission of a newly …